203 related articles for article (PubMed ID: 24799971)
1. Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Njei B; Konjeti VR; Ditah I
Gastrointest Cancer Res; 2014 Mar; 7(2):49-54. PubMed ID: 24799971
[TBL] [Abstract][Full Text] [Related]
2. Treatment and Prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysis.
Glavas D; Bao QR; Scarpa M; Ruffolo C; Brown ZJ; Pawlik TM; Spolverato G
J Gastrointest Surg; 2023 Apr; 27(4):705-715. PubMed ID: 36797535
[TBL] [Abstract][Full Text] [Related]
3. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
[TBL] [Abstract][Full Text] [Related]
4. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma.
Mavros MN; Mayo SC; Hyder O; Pawlik TM
J Am Coll Surg; 2012 Dec; 215(6):820-30. PubMed ID: 22981432
[TBL] [Abstract][Full Text] [Related]
5. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study.
Sempokuya T; Forlemu A; Azawi M; Silangcruz K; Khoury N; Ma J; Wong LL
World J Clin Oncol; 2022 May; 13(5):352-365. PubMed ID: 35662983
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.
Lemekhova A; Hornuss D; Polychronidis G; Mayer P; Rupp C; Longerich T; Weiss KH; Büchler M; Mehrabi A; Hoffmann K
World J Surg Oncol; 2020 May; 18(1):93. PubMed ID: 32397993
[TBL] [Abstract][Full Text] [Related]
8. Clinical prognosis of intraoperative blood salvage autotransfusion in liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis.
Wang Z; Li S; Jia Y; Liu M; Yang K; Sui M; Liu D; Liang K
Front Oncol; 2022; 12():985281. PubMed ID: 36330502
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for fibrolamellar hepatocellular carcinoma: A national perspective.
Atienza LG; Berger J; Mei X; Shah MB; Daily MF; Grigorian A; Gedaly R
J Surg Oncol; 2017 Mar; 115(3):319-323. PubMed ID: 27878821
[TBL] [Abstract][Full Text] [Related]
10. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Qi X; Liu L; Wang D; Li H; Su C; Guo X
Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
[TBL] [Abstract][Full Text] [Related]
11. Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments.
Kassahun WT
World J Surg Oncol; 2016 May; 14(1):151. PubMed ID: 27215576
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review.
He ZX; Xiang P; Gong JP; Cheng NS; Zhang W
Ther Clin Risk Manag; 2016; 12():295-303. PubMed ID: 26966370
[TBL] [Abstract][Full Text] [Related]
13. Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection.
Malouf GG; Brugières L; Le Deley MC; Faivre S; Fabre M; Paradis V; Aerts I; Le Tourneau C; Dreyer C; Branchereau S; Belghiti J; Raymond E
Cancer; 2012 Oct; 118(20):4981-90. PubMed ID: 22415897
[TBL] [Abstract][Full Text] [Related]
14. Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period).
Wahab MA; El Hanafy E; El Nakeeb A; Ali MA
World J Gastrointest Surg; 2017 Feb; 9(2):61-67. PubMed ID: 28289511
[TBL] [Abstract][Full Text] [Related]
17. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.
Pinna AD; Iwatsuki S; Lee RG; Todo S; Madariaga JR; Marsh JW; Casavilla A; Dvorchik I; Fung JJ; Starzl TE
Hepatology; 1997 Oct; 26(4):877-83. PubMed ID: 9328308
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective.
Mayo SC; Mavros MN; Nathan H; Cosgrove D; Herman JM; Kamel I; Anders RA; Pawlik TM
J Am Coll Surg; 2014 Feb; 218(2):196-205. PubMed ID: 24315886
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation vs liver resection in patients with HBV-related hepatocellular carcinoma beyond Milan criterion: A meta-analysis.
Li W; Li L; Han J; Wu H
Clin Transplant; 2018 Mar; 32(3):e13193. PubMed ID: 29315813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
